Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 558 of 1,261
  1. US 10006025

    Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  2. US 10006080

    High-selectivity contact activation inhibitor based on infestin-4

    OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “GEMATOLOGICHESKAYA KORPORATSIYA” · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  3. US 10005741

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  4. US 10006031

    Antisense composition and method for treating muscle atrophy

    Sarepta Therapeutics, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  5. US 10004806

    Periodontal regeneration composition and method of using same

    Periovance, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  6. US 10004800

    Antibody evolution immunogens

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  7. US 10004783

    Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  8. US 10005833

    Methods of treating inflammation associated airway diseases and viral infections

    The Board of Regents of the University of Texas System · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  9. US 10005834

    Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  10. US 10005811

    β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  11. US 10004687

    Liposomal curcumin for treatment of diseases

    The Board of Regents of the University of Texas System · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  12. US 10005780

    Production method of imidazole derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  13. US 10005777

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  14. US 10005767

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  15. US 10005810

    Process for preparing nucleoside prodrugs

    University College Cardiff Consultants Limited · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  16. US 10005815

    Biologically cleavable tetrapeptide linking agents

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  17. US 10005724

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  18. US 10005745

    Amyloid targeting agents and methods of using the same

    The Regents of the University of California · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  19. US 10004785

    LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  20. US 10004751

    Compositions and methods for treating Dengue virus infection

    The Regents of the University of California · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  21. US 10004717

    Glycopyrrolate salts

    Dermira, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  22. US 10004699

    Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

    Acurx Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  23. US 10004729

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  24. US 10004691

    Orally disintegrable tablet

    Takeda Pharmaceutical Company Limited · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.